MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

NREM parasomnias as a marker of cognitive impairment in Parkinson’s disease

B. Minafra, M. Terzaghi, R. Zangaglia, N.G. Pozzi, M. Picascia, R. Cremascoli, E. Sinforiani, N. Vanacore, R. Manni, C. Pacchetti (Pavia, Italy)

Meeting: 2016 International Congress

Abstract Number: 944

Keywords: Sleep disorders. See also Restless legs syndrome: Clinical features

Session Information

Date: Tuesday, June 21, 2016

Session Title: Restless legs syndrome and other sleep disorders

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To identify potential sleep markers of cognitive impairment in Parkinson’s disease (PD) exploring the relationship between V-PSG findings and clinical features.

Background: Sleep disorders and cognitive impairment are frequently reported in Parkinson’s disease (PD) as disabling “non-motor” symptoms. It is known that REM parasomnias (i.e. REM sleep behavior disorder; RBD) predict dementia in PD while little is known about the neurobiological significance of NREM arousal parasomnia-like episodes such as confusional arousals and arousal-related episodes mimicking RBD (so called pseudo RBD) which have been reported to occur in dementia with Lewy bodies (DLB). We report video-PSG findings in patients with PD with different degree of cognitive impairment.

Methods: 170 PD outpatients to underwent to V-PSG. Based on neuropsychological assessment they were assigned to three groups: the first group (G1) without cognitive impairment; the second group (G2) with mild cognitive impairment and the third group (G3)with dementia.

Results: RBD episodes occurred in 43% of the patients, with its single prevalence figures not significantly varying within the groups. Episodes of NREM-arousal parasomnia-like were recorded in 14 % in the first group, 40% in the second and 50% in the third (p 0.002). Interestingly, other eight patients with cognitive impairment removed V-PSG electrodes during a confusional arousal. At multivariate analysis, cognitive impairment significantly increased the risk of NREM arousal parasomnia-like episodes (OR: 4.90; p value 0.045 – CI 95%).

Conclusions: RBD is the most frequent motor behavioural disorder and it can occur at any stage of PD progression. NREM parasomnia appear as a sleep marker of cognitive impairment in PD and could consider as a sleep disorders of advanced Parkinson’s disease.

To cite this abstract in AMA style:

B. Minafra, M. Terzaghi, R. Zangaglia, N.G. Pozzi, M. Picascia, R. Cremascoli, E. Sinforiani, N. Vanacore, R. Manni, C. Pacchetti. NREM parasomnias as a marker of cognitive impairment in Parkinson’s disease [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/nrem-parasomnias-as-a-marker-of-cognitive-impairment-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/nrem-parasomnias-as-a-marker-of-cognitive-impairment-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley